RxDoctor Payments Data

Wendy Reynolds

Nurse Practitioner · Nashville, TNNPI 1194887570

Payments from drug & device makers

$2,870in general payments, 2019–2025

Across 227 payments — averaging $12.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
  • AbbVie$1K
  • Aimmune Therapeutics, Inc.$267
  • Johnson & Johnson$162
  • Nestle Healthcare Nutrition Inc.$45
  • Redhill Biopharma Inc.$35
  • plus $126 from 6 others

What the payments were for

  • Food & beverage$2,77197%
  • Education$993%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,870 in reported general payments places this provider in the 85th percentile of 2,662 nurse practitioner providers in Tennessee.

See all nurse practitioner providers in Tennessee

Medicare billing

Part B allowed, 2024
$14,780
Medicare patients
146
Services billed
201

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide46$39,689
CreonLipase/Protease/Amylase16$25,511
MotegrityPrucalopride Succinate19$14,900
Ursodiol29$6,290
Balsalazide Disodium23$4,723
Dexlansoprazole DrDexlansoprazole17$4,368
MovantikNaloxegol Oxalate11$3,950
Dicyclomine Hcl101$2,727
Omeprazole174$2,420
Ondansetron Hcl42$2,126
Pantoprazole Sodium134$1,987
CholestyramineCholestyramine (With Sugar)32$1,887
Famotidine147$1,825
Esomeprazole Magnesium28$1,352
Colestipol Hcl25$1,264

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess, Creon$1,016$65,20062 claims
Takeda Pharmaceuticals U.S.A., Inc.Motegrity$23$14,90019 claims
Redhill Biopharma Inc.Movantik$35$3,95011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,662 nurse practitioner providers in Tennessee.

Other nurse practitioner in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →